Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | coagulation factor II (thrombin) | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Probable 3',5'-cyclic phosphodiesterase R153.1, putative | 0.037 | 0.2981 | 1 |
Brugia malayi | astacin protease protein 30 | 0.0124 | 0.0163 | 0.0545 |
Loa Loa (eye worm) | hypothetical protein | 0.0191 | 0.0938 | 0.0938 |
Echinococcus granulosus | laminin | 0.0318 | 0.2379 | 0.0971 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0422 | 0.3567 | 0.3212 |
Brugia malayi | Fibulin-1 precursor | 0.0318 | 0.2379 | 0.7982 |
Mycobacterium ulcerans | hydrolase | 0.0133 | 0.0272 | 0.5 |
Loa Loa (eye worm) | cyclic AMP specific phosphodiesterase PDE4D5A | 0.037 | 0.2981 | 0.2981 |
Schistosoma mansoni | P2X receptor subunit | 0.0246 | 0.1559 | 0.1094 |
Loa Loa (eye worm) | low-density lipoprotein receptor repeat class B containing protein | 0.0286 | 0.2013 | 0.2013 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0133 | 0.0272 | 0.0913 |
Loa Loa (eye worm) | zinc metalloproteinase toh-2 | 0.0124 | 0.0163 | 0.0163 |
Brugia malayi | zinc metalloproteinase toh-2 precursor | 0.0124 | 0.0163 | 0.0545 |
Brugia malayi | Low-density lipoprotein receptor repeat class B containing protein | 0.0286 | 0.2013 | 0.6756 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0422 | 0.3567 | 0.2378 |
Loa Loa (eye worm) | multiple epidermal growth factor-like domains 6 | 0.0318 | 0.2379 | 0.2379 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0422 | 0.3567 | 0.2378 |
Brugia malayi | Zinc metalloproteinase toh-2 precursor | 0.0124 | 0.0163 | 0.0545 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0133 | 0.0272 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.2013 | 0.2013 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.037 | 0.2981 | 0.1684 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.048 | 0.4229 | 0.3163 |
Echinococcus multilocularis | fibrillin 1 | 0.0318 | 0.2379 | 0.0971 |
Loa Loa (eye worm) | hypothetical protein | 0.0401 | 0.3333 | 0.3333 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 0.0071 | 0.0071 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0243 | 0.1521 | 0.6186 |
Brugia malayi | Calcium binding EGF domain containing protein | 0.0318 | 0.2379 | 0.7982 |
Brugia malayi | Nematode astacin protease protein 30 | 0.0124 | 0.0163 | 0.0545 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0422 | 0.3567 | 1 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0422 | 0.3567 | 0.2378 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0422 | 0.3567 | 0.2378 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.0272 | 0.0272 |
Loa Loa (eye worm) | bone morphogenetic protein 1b | 0.0985 | 1 | 1 |
Brugia malayi | Nematode astacin protease protein 30 | 0.0124 | 0.0163 | 0.0545 |
Loa Loa (eye worm) | hypothetical protein | 0.0422 | 0.3567 | 0.3567 |
Loa Loa (eye worm) | hypothetical protein | 0.0945 | 0.9542 | 0.9542 |
Brugia malayi | Calcium binding EGF domain containing protein | 0.0116 | 0.0071 | 0.0237 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.048 | 0.4229 | 0.3163 |
Onchocerca volvulus | 0.0124 | 0.0163 | 0.0661 | |
Onchocerca volvulus | Arrow homolog | 0.0286 | 0.2013 | 0.8189 |
Echinococcus multilocularis | laminin | 0.0318 | 0.2379 | 0.0971 |
Schistosoma mansoni | subfamily M12A unassigned peptidase (M12 family) | 0.0985 | 1 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0246 | 0.1559 | 0.1094 |
Loa Loa (eye worm) | matrixin family protein | 0.0243 | 0.1521 | 0.1521 |
Loa Loa (eye worm) | matrixin family protein | 0.0347 | 0.2708 | 0.2708 |
Loa Loa (eye worm) | hypothetical protein | 0.0318 | 0.2379 | 0.2379 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0191 | 0.0938 | 0.0439 |
Brugia malayi | Matrixin family protein | 0.0347 | 0.2708 | 0.9087 |
Loa Loa (eye worm) | DPY-31 protein | 0.0124 | 0.0163 | 0.0163 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.0163 | 0.0163 |
Echinococcus multilocularis | Tolloid protein 1 | 0.0985 | 1 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0246 | 0.1559 | 0.1094 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.2013 | 0.2013 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0133 | 0.0272 | 0.5 |
Giardia lamblia | CAMP-specific 3,5-cyclic phosphodiesterase 4B | 0.0422 | 0.3567 | 0.5 |
Onchocerca volvulus | Matrilysin homolog | 0.0325 | 0.2459 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0246 | 0.1559 | 0.1094 |
Onchocerca volvulus | Putative cubilin | 0.0116 | 0.0071 | 0.0287 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.037 | 0.2981 | 0.1684 |
Brugia malayi | Hemopexin family protein | 0.0155 | 0.0522 | 0.1751 |
Onchocerca volvulus | 0.0155 | 0.0522 | 0.2123 | |
Loa Loa (eye worm) | AStacin protease | 0.0616 | 0.5784 | 0.5784 |
Schistosoma mansoni | egf-like domain protein | 0.0286 | 0.2013 | 0.1574 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2700 nM | Compound was measured for the inhibition of alpha-human thrombin by amidolytic assay | ChEMBL. | No reference |
IC50 (binding) | = 2700 nM | Compound was measured for the inhibition of alpha-human thrombin by amidolytic assay | ChEMBL. | No reference |
Ki (binding) | = 310 nM | Compound was measured for the inhibition of alpha-human thrombin by clotting test | ChEMBL. | No reference |
Ki (binding) | = 310 nM | Compound was measured for the inhibition of alpha-human thrombin by clotting test | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.